ConductScience.org, home

Paper8538705

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

Gustafsson L and 4 others. N Engl J Med, 1996. Cited by 607 papers, by iCite.

Cite this record

ConductScience Library. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Papers, record 8538705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8538705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
PubMed
Journal
N Engl J Med
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
607
iCite
Relative citation ratio, by iCite
19.3
iCite
Revised in PubMed
2022-03-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gustafsson LL
2Hallander HOH O
3Olin PP
4Reizenstein EE
5Storsaeter JJ

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pertussis VaccineMajor topic
Whooping CoughMajor topic
Antibodies, Bacterial
Antigens, Bacterial
Bordetella pertussis
Diphtheria Toxoid
Diphtheria-Tetanus Vaccine
Diphtheria-Tetanus-Pertussis Vaccine
Double-Blind Method
Female
Humans
Immunoglobulin G
Infant
Male
Tetanus Toxoid
Treatment Outcome
Vaccines, Combined
Vaccines, Inactivated
Virulence Factors, Bordetella

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N01-AI-15125NIAID NIH HHSUnited StatesN01AI015125PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8538712Acellular pertussis vaccines for infants.https://conductscience.org/library/papers/8538712

Source PubMed

Download CSV of comments and corrections

Cited by193

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 607 citations.

PMIDTitleJournalYearIn PapersSource
42797595Whole-Cell and Acellular Pertussis Vaccines: A Narrative Review of Biological, Clinical, Safety and Programmatic Evidence, with Implications for Poland.Vaccines (Basel)2026https://conductscience.org/library/papers/42797595PubMed
42477039Post-exposure booster vaccination recalls vaccine-induced memory and accelerates Bordetella pertussis clearance in murine lungs and trachea.Sci Rep2026https://conductscience.org/library/papers/42477039PubMed
42437472Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review.Acta Paediatr2026https://conductscience.org/library/papers/42437472PubMed
42347613Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1.Vaccines (Basel)2026https://conductscience.org/library/papers/42347613PubMed
42060701SeaB is a conserved Salmonella enterica extracellular matrix binding protein involved in biofilm formation and infection.Infect Immun2026https://conductscience.org/library/papers/42060701PubMed
41770752Comparative analysis of the diversity within the B. bronchiseptica fimX locus.PLoS One2026https://conductscience.org/library/papers/41770752PubMed
41214155Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice.Nat Microbiol2025https://conductscience.org/library/papers/41214155PubMed
40842393Resurgence of pertussis: whopping the '100-day cough'.Curr Opin Pediatr2025https://conductscience.org/library/papers/40842393PubMed
40689608Variation in virulence between three representative Bordetella pertussis pertactin-negative clinical isolates.mSphere2025https://conductscience.org/library/papers/40689608PubMed
40540779Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel.Vaccine2025https://conductscience.org/library/papers/40540779PubMed
39684849Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.Int J Mol Sci2024https://conductscience.org/library/papers/39684849PubMed
39669568Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection.Front Immunol2024https://conductscience.org/library/papers/39669568PubMed
39565788High pertussis circulation among infants, children and adolescents in Abidjan, Côte d'Ivoire.PLoS One2024https://conductscience.org/library/papers/39565788PubMed
39441011A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge.mSphere2024https://conductscience.org/library/papers/39441011PubMed
39417957Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023.Infection2025https://conductscience.org/library/papers/39417957PubMed
39218947Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections.NPJ Vaccines2024https://conductscience.org/library/papers/39218947PubMed
39205626The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.Hum Vaccin Immunother2024https://conductscience.org/library/papers/39205626PubMed
38857311
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial.
PLoS Med2024https://conductscience.org/library/papers/38857311PubMed
38752005Safety assessments of recombinant DTaP vaccines developed in South Korea.Clin Exp Vaccine Res2024https://conductscience.org/library/papers/38752005PubMed
37565807Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model.J Infect Dis2024https://conductscience.org/library/papers/37565807PubMed

See all 193 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8538705

GET https://conductscience.org/api/papers/v1/8538705/cited_by?page=2